Article
High mutations in fatty acid metabolism contribute to a better prognosis of small-cell lung cancer patients treated with chemotherapy.
Cancer medicine - 1 Nov 2021
Lyu Qiong, Zhu Weiliang, Wei Ting, Ding Weimin, Cao Manming, Wang Qiongyao, Guo Linlang, Luo Peng, Zhang Jian
Abstract excerpt
BACKGROUND: The majority of patients with small-cell lung cancer (SCLC) show a good response in the early stages of treatment, but more than 90% of patients will develop drug resistance. Therefore, biomarkers are urgently needed to identify patients who can benefit from systemic treatment. METHODS: We prospectively enrolled 52 extensive-stage SCLC patients before treatment from a local hospital to identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
